Therapeutic Potential of Injectable Nano-Mupirocin Liposomes for Infections Involving Multidrug-Resistant Bacteria
Antibiotic resistance is a global health threat. There are a few antibiotics under development, and even fewer with new modes of action and no cross-resistance to established antibiotics. Accordingly, reformulation of old antibiotics to overcome resistance is attractive. Nano-mupirocin is a PEGylate...
Main Authors: | Ahuva Cern, Yaelle Bavli, Atara Hod, Daniel Zilbersheid, Shazad Mushtaq, Ayelet Michael-Gayego, Dinorah Barasch, Yael Feinstein Rotkopf, Allon E. Moses, David M. Livermore, Yechezkel Barenholz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/12/2186 |
Similar Items
-
Screening for Mupirocin Resistance in Staphylococcus
by: AVR JEYA SANJU, et al.
Published: (2015-10-01) -
IN VITRO ACTIVITY AND EMERGENCE OF RESISTANCE TO MUPIROCIN IN STAPHYLOCOCCUS AUREUS
by: Margalida Rotger, et al.
Published: (2003-10-01) -
A Case Report of Subcutaneously Injected Liposomal Cannabidiol Formulation Used as a Compassion Therapy for Pain Management in a Dog
by: Yael Shilo-Benjamini, et al.
Published: (2022-04-01) -
Identification o f Clinical Methicillin and Mupirocin-resistant Staphylococcus aureus by Multiplex-PCR
by: Abazar Pournajaf, et al.
Published: (2015-10-01) -
Mupirocin resistance in methicillin-resistant Staphylococcus aureus isolates from anterior nares of healthcare workers of a tertiary care hospital
by: Manjushree V. Mulay, et al.
Published: (2022-04-01)